olmesartan has been researched along with Cardiomyopathy, Dilated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jo, S; Kim, J; Kim, SH; Kwon, YS; Moon, H; Park, K; Sohn, CB | 1 |
| Aizawa, Y; Gurusamy, N; Kodama, M; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
1 trial(s) available for olmesartan and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Design and rationale for a comparison study of Olmesartan and Valsartan On myocardial metabolism In patients with Dilated cardiomyopathy (OVOID) trial: study protocol for a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Humans; Imidazoles; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valsartan; Young Adult | 2022 |
1 other study(ies) available for olmesartan and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomyopathy, Dilated; Chemokine CCL2; Imidazoles; Interleukin-1beta; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocarditis; Myocardium; Myosins; Rats; Rats, Inbred Lew; RNA, Messenger; Tetrazoles; Ventricular Remodeling | 2010 |